Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10

Immunity
Adriana IrimiaIan A Wilson

Abstract

Numerous studies of the anti-HIV-1 envelope glycoprotein 41 (gp41) broadly neutralizing antibody 4E10 suggest that 4E10 also interacts with membrane lipids, but the antibody regions contacting lipids and its orientation with respect to the viral membrane are unknown. Vaccine immunogens capable of re-eliciting these membrane proximal external region (MPER)-like antibodies may require a lipid component to be successful. We performed a systematic crystallographic study of lipid binding to 4E10 to identify lipids bound by the antibody and the lipid-interacting regions. We identified phosphatidic acid, phosphatidylglycerol, and glycerol phosphate as specific ligands for 4E10 in the crystal structures. 4E10 used its CDRH1 loop to bind the lipid head groups, while its CDRH3 interacted with the hydrophobic lipid tails. Identification of the lipid binding sites on 4E10 may aid design of immunogens for vaccines that include a lipid component in addition to the MPER on gp41 for generation of broadly neutralizing antibodies.

References

Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R C AloiaF C Jensen
Apr 16, 2003·Annals of the Rheumatic Diseases·R A Asherson, R Cervera
Aug 19, 2006·IUBMB Life·Rosanna CazzolliWilliam E Hughes
Jul 14, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sylvain ParuchAxel Périanin
Nov 23, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Miao-Ping ChienDing-Kwo Chang
Jan 25, 2008·Nature Reviews. Molecular Cell Biology·Gerrit van MeerGerald W Feigenson
Mar 7, 2008·Proceedings of the National Academy of Sciences of the United States of America·Gary FreyBing Chen
Jul 4, 2008·Nature Structural & Molecular Biology·Stephen C Harrison
Oct 18, 2008·La Revue de médecine interne·D SèneP Cacoub
Dec 23, 2008·Biochimica Et Biophysica Acta·Gary R MatyasCarl R Alving
May 16, 2009·Journal of Computational Chemistry·B R BrooksM Karplus
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Nov 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·S Munir AlamBing Chen
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Erin M SchererDennis R Burton
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Nov 26, 2010·Journal of Peptide Science : an Official Publication of the European Peptide Society·Sampat IngalePhilip E Dawson
Aug 19, 2011·Nature·Laura M WalkerPascal Poignard
Apr 5, 2012·AIDS·Tae-Wook Chun, Anthony S Fauci
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Wesley I Sundquist, Hans-Georg Kräusslich
Jul 19, 2012·PLoS Pathogens·Erin E H TranSriram Subramaniam
Jan 30, 2013·The Journal of Experimental Medicine·Guang YangGarnett Kelsoe
Jul 5, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yao ChenLaurent Verkoczy
Aug 14, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Colleen Doyle-CooperDavid Nemazee
Nov 2, 2013·Science·Jean-Philippe JulienIan A Wilson

❮ Previous
Next ❯

Citations

May 12, 2016·Annual Review of Immunology·Dennis R Burton, Lars Hangartner
Jan 31, 2017·Immunological Reviews·Laura E McCoy, Dennis R Burton
Sep 27, 2019·Immunological Reviews·Deborah L BurnettChristopher C Goodnow
Feb 19, 2017·The Journal of Biological Chemistry·Edurne RujasJosé L Nieva
Nov 28, 2019·Nature Communications·Lei ZhangMichael B Zwick
Apr 20, 2017·Current Opinion in HIV and AIDS·Nichole CeruttiWinfried Weissenhorn
Sep 1, 2018·Protein Engineering, Design & Selection : PEDS·Joerg Thomas RegulaChristian Klein
Sep 7, 2018·Proceedings of the National Academy of Sciences of the United States of America·Qingshan FuJames J Chou
Jan 10, 2019·Nature Communications·Pablo CarravillaJosé L Nieva
May 1, 2018·Peptide Science·Christopher A MacRaildRaymond S Norton
Oct 19, 2019·Proceedings of the National Academy of Sciences of the United States of America·Yi WangMikyung Kim
Apr 20, 2017·Current Opinion in HIV and AIDS·Marie PanceraPeter D Kwong
Aug 8, 2017·Science Immunology·LaTonya D WilliamsBarton F Haynes
Dec 4, 2019·Biophysical Journal·Pablo CarravillaJose Requejo-Isidro
Oct 30, 2020·Viruses·Christophe CaillatWinfried Weissenhorn
Mar 6, 2021·Scientific Reports·Rishikesh MagarAmir Barati Farimani
Mar 8, 2021·Journal of Molecular Biology·Benjamin C McIlwainRandy B Stockbridge
Apr 30, 2020·Cell Reports·Kimmo RantalainenAndrew B Ward
Jul 18, 2021·The Journal of Biological Chemistry·June Ereño-OrbeaJean-Philippe Julien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.